These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21639993)

  • 21. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles.
    Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE
    J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite.
    Ho ML; Fu YC; Wang GJ; Chen HT; Chang JK; Tsai TH; Wang CK
    J Control Release; 2008 Jun; 128(2):142-8. PubMed ID: 18436324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
    Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an in situ forming PLGA drug delivery system I. Characterization of a non-aqueous protein precipitation.
    Körber M; Bodmeier R
    Eur J Pharm Sci; 2008 Nov; 35(4):283-92. PubMed ID: 18721875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery.
    Li JK; Wang N; Wu XS
    J Pharm Sci; 1997 Aug; 86(8):891-5. PubMed ID: 9269865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long acting porous microparticle for pulmonary protein delivery.
    Kwon MJ; Bae JH; Kim JJ; Na K; Lee ES
    Int J Pharm; 2007 Mar; 333(1-2):5-9. PubMed ID: 17296275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled protein release from monodisperse biodegradable double-wall microspheres of controllable shell thickness.
    Xia Y; Ribeiro PF; Pack DW
    J Control Release; 2013 Dec; 172(3):707-14. PubMed ID: 23954731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of osmotic pressure in the solvent extraction phase on BSA release profile from PLGA microspheres.
    Jiang G; Thanoo BC; DeLuca PP
    Pharm Dev Technol; 2002 Nov; 7(4):391-9. PubMed ID: 12503521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release.
    Lu Y; Yu Y; Tang X
    J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV; Olivier JC
    Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
    Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
    Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.
    Zhou YZ; Alany RG; Chuang V; Wen J
    Drug Dev Ind Pharm; 2013 Feb; 39(2):321-30. PubMed ID: 22607101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo.
    Lin X; Wang J; Xu Y; Tang X; Chen J; Zhang Y; Zhang Y; Yang Z
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1455-65. PubMed ID: 26790718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
    Amjadi I; Rabiee M; Hosseini MS; Mozafari M
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres.
    Pérez C; Griebenow K
    Biotechnol Bioeng; 2003 Jun; 82(7):825-32. PubMed ID: 12701149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique.
    Paillard-Giteau A; Tran VT; Thomas O; Garric X; Coudane J; Marchal S; Chourpa I; Benoît JP; Montero-Menei CN; Venier-Julienne MC
    Eur J Pharm Biopharm; 2010 Jun; 75(2):128-36. PubMed ID: 20226857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.